| GFAFX | HRCIX | GFAFX / HRCIX | |
| Total Expense Ratio | 0.67 | 0.75 | 89% |
| Annual Report Gross Expense Ratio | 0.67 | 0.75 | 89% |
| Fund Existence | 25 years | 20 years | - |
| Gain YTD | 15.157 | 20.050 | 76% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 10000 | 3% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 330B | 570M | 57,895% |
| Annual Yield % from dividends | 0.28 | 0.00 | 6,311% |
| Returns for 1 year | 7.10 | 9.50 | 75% |
| Returns for 3 years | 61.85 | 42.87 | 144% |
| Returns for 5 years | 32.96 | 22.10 | 149% |
| Returns for 10 years | 88.41 | 73.16 | 121% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FTXH | 31.90 | 0.36 | +1.14% |
| First Trust Nasdaq Pharmaceuticals ETF | |||
| SDSI | 51.59 | 0.05 | +0.10% |
| American Century® Short Dur Str Inc ETF | |||
| IBMQ | 25.52 | 0.01 | +0.06% |
| iShares iBonds Dec 2028 Term Muni Bd ETF | |||
| THIR | 31.18 | -0.25 | -0.78% |
| THOR Index Rotation ETF | |||
| FBCG | 52.25 | -0.73 | -1.38% |
| Fidelity Blue Chip Growth ETF | |||